Related Experiment Videos
Pediatric heart-lung transplantation for cystic fibrosis
1Harefield Hospital, Middlesex, Great Britain.
Insights
Heart-lung transplantation offers a promising treatment for children with cystic fibrosis, with most patients alive and well one year post-surgery. Early results indicate successful return to schooling despite some complications.
Area of Science:
- Pediatric Surgery
- Cardiothoracic Transplantation
- Cystic Fibrosis Management
Background:
- Cystic fibrosis (CF) significantly impacts lung and heart function, often necessitating advanced interventions.
- Heart-lung transplantation (HLT) is a potential, albeit complex, treatment option for pediatric CF patients with end-stage cardiopulmonary disease.
Purpose of the Study:
- To detail the preoperative and postoperative experiences of pediatric patients undergoing heart-lung transplantation for cystic fibrosis.
- To assess the short-term outcomes and identify common complications in this specific patient cohort.
Main Methods:
- Retrospective descriptive study design.
- Inclusion of twelve pediatric patients (age 7-14 years) who underwent HLT between 1987 and 1991.
- Data collection focused on surgical procedures, postoperative recovery, and patient survival.
Main Results:
- All 12 children survived the first postoperative year, with one requiring retransplantation.
- Actuarial survival rate reached 66% at the 2-year mark post-transplantation.
- Despite complications like immunosuppressant malabsorption and infections, 66% of patients returned to school within the first year.
Conclusions:
- Early findings support heart-lung transplantation as a viable therapeutic strategy for pediatric cystic fibrosis.
- Postoperative challenges include CF-specific issues (malabsorption, meconium ileus, infections) and general transplant complications (rejection, infection).
- Obliterative bronchiolitis remains a critical long-term concern, highlighting the need for further research into its prevention and management.
Objective:
To describe the preoperative and postoperative experience of children who have undergone heart-lung transplantation for cystic fibrosis.
Design:
Retrospective descriptive study.
Setting:
Paediatric Surgical Unit, Harefield Hospital, Middlesex, Great Britain.
Patients:
Twelve children less than 15 years of age (mean age 11 years 10 months; range 7 to 14 years), six boys and six girls, who received heart-lung transplants between September 1987 and March 1991.
Results:
All 12 children were alive and well 1 year after surgery, although one girl had undergone retransplantation in the eighth postoperative month. Actuarial survival rate was 66% at 2 years.
Conclusions:
Early results suggest that heart-lung transplantation is a successful therapeutic option for children with cystic fibrosis. Cystic fibrosis-related postoperative complications were malabsorption of immunosuppressive drugs, meconium ileus equivalent, and persisting infection in the upper respiratory tract. These and general complications of acute rejection and infection did not prevent 66% of the group from returning to their normal schooling within the first postoperative year. Obliterative bronchiolitis remains the most serious late complication after lung transplantation, and further research is needed into treatment and prevention.